NuVasive receives FDA clearance to expand interlock device's applications for cervical spine

Alan Condon -   Print  |

The FDA recently granted NuVasive 510(k) clearance to expand its CoRent Small Interlock system for multilevel use in cervical spine surgery.

Four insights:

1. The CoRent device is now expanded for use at multiple adjacent levels from C2-T1 for anterior cervical discectomy and fusion procedures.

2. The device is an anterior cervical interbody fusion system intended for use in patients suffering from cervical disc degeneration and/or cervical spinal instability.

3. It is a no-profile interfixated interlock system that is implanted within the vertebral disc.

4. CoRent features a zero-step locking mechanism, a large fusion space, angled instrumentation for difficult implantation areas and a three-screw design that improves interbody placement.

More articles on devices:
19 spine devices receive FDA 510(k) clearance in October
Medtronic Q2 spine revenue up 5.5%
Orthofix M6-C cervical disc in 2019: 7 key developments  

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers